Antiviral composition comprising glycine amide
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Mar 14, 2006
Grant Date -
Feb 26, 2004
app pub date -
Apr 1, 2003
filing date -
Sep 19, 2001
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Embodiments relate to the discovery that certain tripeptide amides and glycine amide can be used to inhibit viral infection, including human immunodeficiency virus (HIV) infection. More specifically, medicaments comprising said tripeptide amides and/or glycine amide and methods of using said compounds for the prevention and treatment of viral infection, such as HIV infection, are provided.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully